{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:24:57Z","timestamp":1780637097416,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,11,1]],"date-time":"2010-11-01T00:00:00Z","timestamp":1288569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1016\/j.yebeh.2010.08.007","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T09:18:10Z","timestamp":1284628690000},"page":"405-408","source":"Crossref","is-referenced-by-count":101,"title":["Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China"],"prefix":"10.1016","volume":"19","author":[{"given":"X.T.","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.M.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2010.08.007_bb0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1212\/WNL.49.2.542","article-title":"Risk of serious cutaneous disorders after initiation of use of phenytoin, carbamazepine, or sodium valproate: a record linkage study","volume":"49","author":"Tennis","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0010","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1212\/01.wnl.0000261917.83337.db","article-title":"Comparison and predictors of rash associated with 15 antiepileptic drugs","volume":"68","author":"Arif","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0015","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1212\/01.WNL.0000156354.20227.F0","article-title":"Risk of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics","volume":"64","author":"Mockenhaupt","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0020","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2217\/17410541.2.3.225","article-title":"HLA-B genotyping to detect carbamazepine-induced Stevens\u2013Johnson syndrome: implications for personalizing medicine","volume":"2","author":"Hung","year":"2005","journal-title":"Personalized Med"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0025","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(24)01501-1","article-title":"Cutaneous drug reactions","volume":"53","author":"Svensson","year":"2001","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/ACI.0b013e3282370c5f","article-title":"Human leukocyte antigens and drug hypersensitivity","volume":"7","author":"Chung","year":"2007","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0035","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genom"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/j.1528-1167.2007.01022.x","article-title":"Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions","volume":"48","author":"Man","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0045","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/WCO.0b013e328328f276","article-title":"Genetics basis for idiosyncratic reactions to antiepileptic drugs","volume":"22","author":"Franciotta","year":"2009","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0050","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.ajhg.2009.10.016","article-title":"Genetic structure of the Han Chinese population revealed by genome-wide SNP variation","volume":"85","author":"Chen","year":"2009","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0055","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/1523-1747.ep12388434","article-title":"The spectrum of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a clinical classification","volume":"102","author":"Roujeau","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0060","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0140-6736(95)90581-2","article-title":"Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy","volume":"345","author":"Brodie","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0065","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0031-6997(24)01501-1","article-title":"Cutaneous drug reactions","volume":"53","author":"Svensson","year":"2000","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0070","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens\u2013Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0075","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1111\/j.1528-1167.2008.01719.x","article-title":"Carbamazepine and phenytoin induced Stevens\u2013Johnson syndrome is associated with HLA-B*1502 allele in Thai population","volume":"49","author":"Locharernkul","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0080","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","article-title":"Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients","volume":"10","author":"Kashiwagi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0085","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1528-1167.2009.02269.x","article-title":"HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions","volume":"51","author":"Ikeda","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0090","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0095","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/sj.tpj.6500356","article-title":"for the RegiSCAR Group. A marker for Stevens\u2013Johnson syndrome: ethnicity matters","volume":"6","author":"Lonjou","year":"2006","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0100","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1517\/14740330903427969","article-title":"Genetic predisposition of life-threatening antiepileptic-induced skin reactions","volume":"9","author":"Chung","year":"2010","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0105","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-2008-1079336","article-title":"Adverse effects of antiepileptic drugs","volume":"28","author":"Toledano","year":"2008","journal-title":"Semin Neurol"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0110","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1528-1157.1997.tb01252.x","article-title":"Safety of long-term lamotrigine in epilepsy","volume":"38","author":"Mackay","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1528-1167.2006.00423.x","article-title":"Predictors of lamotrigine-associated rash","volume":"47","author":"Hirsch","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1528-1157.1999.tb00807.x","article-title":"Lamotrigine associated rash: risk\/benefit considerations in adults and children","volume":"40","author":"Guberman","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2010.08.007_bb0125","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1528-1167.2007.01109.x","article-title":"Rash from antiepileptic drugs: influence by gender, age, and learning disability","volume":"48","author":"Alvestad","year":"2007","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501000541X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152550501000541X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T21:40:17Z","timestamp":1740519617000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152550501000541X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["S152550501000541X"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2010.08.007","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2010,11]]}}}